Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "iibs"

RBI should be careful on relaxing prudential regulations...

Putting the onus on the government to subsidise activities of national importance, RBI Governor Raghuram Rajan said that the RBI has to be careful about relaxing prudential regulations in these cases as it may pose systemic risks. "While the RBI is a ... Deccan Herald, 3 days ago

97 images for iibs

Nasdaq, 1 week ago
Invest In Brussels, 2 weeks ago
EuroInvestor, 2 weeks ago, 2 weeks ago
EuroInvestor, 2 weeks ago
Drug Development Technology, 3 weeks ago
Nation's Restaurant News, 3 weeks ago
Asian Hospital & Healthcare Management, 3 weeks ago
Asian Hospital & Healthcare Management, 3 weeks ago, 1 month ago

10 Biggest Mid-Day Losers For Monday

Performance Sports Group Ltd (NYSE: PSG ) shares dipped 61.5 percent to $1.34. Performance Sports reported that it would not file its Annual Report on Form 10-K by the August 15, 2016 deadline. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) shares ...
 Benzinga.com2 weeks ago

Mid-Day Market Update: Sorl Auto Parts Gains Following Q2 Results; Performance Sports Shares Slide

Midway through trading Monday, the Dow traded up 0.45 percent to 18,660.50 while the NASDAQ climbed 0.69 percent to 5,268.75. The S&P also rose, gaining 0.42 percent to 2,193.29. Leading and Lagging Sectors Monday morning, the basic materials ...
 Benzinga.com2 weeks ago

Aurinia's shares plummet on deaths in mid-stage study of experimental lupus nephritis drug voclosporin

Shares in Aurinia Pharmaceuticals dropped asmuch as 56.6 percent Monday after the company disclosed that 13 patients died in a mid-stage study ofvoclosporin, including 12 who received the investigational lupus nephritis drug. However, the company ...
 FirstWord Pharma2 weeks ago Aurinia lupus candidate hits PhII target, but deaths send stock down  FierceBiotech2 weeks ago Aurinia's lupus drug shown to improve remission rates  Stockwatch2 weeks ago Aurinia Pharmaceuticals Announces Voclosporin Meets Primary Endpoint in Phase IIB AURA-LV Study in Lupus Nephritis  Minyanville2 weeks ago
Physician's Briefing

Arhalofenate Beats Allopurinol for Gout Flares

MONDAY, Aug. 15, 2016 (HealthDay News) -- Arhalofenate (800 mg) is safe and significantly decreases gout flares compared to allopurinol (300 mg), according to a study published online July 27 in Arthritis & Rheumatology . Jeffrey Poiley, M.D., ...
 Physician's Briefing2 weeks ago


Forward-Looking Statements and Associated Risks This section and other parts of this Form 10-Q contain forward-looking statements. Forward-looking statements provide current expectations of future events based on certain assumptions and include any ...
 4 Traders2 weeks ago TG THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)  4 Traders2 weeks ago OPEXA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)  4 Traders2 weeks ago

Mid-Morning Market Update: Markets Open Higher; SYSCO Profit Tops Estimates

Following the market opening Monday, the Dow traded up 0.36 percent to 18,644.27 while the NASDAQ climbed 0.40 percent to 5,253.64. The S&P also rose, gaining 0.26 percent to 2,189.61. Leading and Lagging Sectors Monday morning, the basic ...
 Benzinga.com2 weeks ago 2016 State of the Markets Mid-Year Update  SlideShare.net2 weeks ago

Lupus Foundation of America Statement on Successful Results of Phase IIB Clinical Trial of Voclosporin

) - Today Aurinia Pharmaceutical Company announced positive top-line results of a Phase IIB clinical study of voclosporin, a potential new therapy option for people with active lupus nephritis (lupus-related kidney disease). The study met its ...
 Digital Journal2 weeks ago ArticleAblynx releases strong top-line data on vobarilizumab in RA09-08-2016  Pharma Letter2 weeks ago Oramed Pharmaceuticals' (ORMP) CEO Nadav Kidron Hosts Phase IIb Clinical Results Conference (Transcript)  Seeking Alpha1 month ago

12 Stocks Moving In Monday's Pre-Market Session

Gainers Kingold Jewelry Inc (NASDAQ: KGJI ) rose 50.7 percent to $3.09 in pre-market trading as the company reported Q2 results on Friday. Q2 EPS of $0.30 compared to last quarter's $0.01, while revenue of $390.3 million was substantially higher ...
 Benzinga.com2 weeks ago

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2016

) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The ...
 Sys-Con Media2 weeks ago Moleculin Biotech Inc (MBRX): Proceed With Caution  InsiderMonkey.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less